Got a text today asking if I was interested in participating in a clinical trial for knee osteoarthritis.
It is early days - Phase 1A. The company is Cytonics and the drug CYT-108.
I've started researching a little and I'm reading some familiar themes.... 'Holy grail'....... 'may be the first and only disease-modifying pharmaceutical for OA'....... 'aim to partner with a mid-sized pharmaceutical company' ...... sound familiar?
They make interesting claims like:
In our preclinical studies, CYT-108 showcased promising results that emphasize its potential efficacy and safety. CYT-108 demonstrated up to 60% reduction in cartilage degradation and joint membrane inflammation compared to controls, and it was well-tolerated by the study subjects.
It's intraarticular. Haven't learnt much more yet.
If anyone knows much more about it, would love to hear.
There are a number of links but this one I found particularly interesting.
Mozz, I've got a feeling you've mentioned this one before????
- Forums
- ASX - By Stock
- New Player
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.20%
!
46.5¢

Got a text today asking if I was interested in participating in...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $184.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $517.4K | 1.132M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 57329 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 0.460 |
5 | 38097 | 0.450 |
3 | 36377 | 0.445 |
4 | 123125 | 0.440 |
3 | 111090 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 19077 | 2 |
0.470 | 3377 | 2 |
0.475 | 57830 | 4 |
0.480 | 112895 | 5 |
0.485 | 20000 | 2 |
Last trade - 15.52pm 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online